Associate principal scientist
AstraZeneca Pharmaceuticals
Waltham, Massachusetts
Stacey Marden is an Associate Principal Scientist in the Advenced Drug Delivery group within the R&D Pharmaceutical Sciences team at AstraZeneca with over 30 years’ experience in the pharmaceutical industry. She has been involved in all phases of pharmaceutical development and is currently working in the pre-clinical space. She greatly enjoys the scientific challenges encompassing new molecular entities and is tenacious to discover their hidden secrets. Stacey is a member of the AstraZeneca global Degradation Network and is actively involved in the International Forced Degradation Community (IFDC), a cross-pharma group whose purpose is to study and recommend best practices for performing forced degradation studies. Since finishing her PhD at the University of Massachusetts, she has held many roles over the years including project lead for compounds transitioning from discovery to development, group leader, and business lead for a departmental LIMS system. Personally, Stacey is an outdoor enthusiast, a bird watcher, and enjoys cycling to work as often as possible.
Disclosure information not submitted.
A Unified Approach to Mass Balance in Pharmaceutical Stress Testing
Tuesday, July 15, 2025
10:35 AM - 11:05 AM ET
Ensuring Patient Safety through Analytical Control of Impurities Across Modalities: Panel Discussion
Tuesday, July 15, 2025
11:05 AM - 11:55 AM ET